TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Pregnant Women Education in Case of Overweight or Obesity on Risk of Child Overweight and Pregnancy Outcome
Brief Summary: Metabolic environment of the foetus during pregnancy in obese women is altered and the child exposed at an increased risk of obesity. Rapid infancy and childhood weight gain is associated with subsequent obesity.

The purpose of the study is to test the efficacy of an educational intervention during pregnancy in obese or overweight women, on the reduction of rapid infancy weight gain in the two first years of life.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Therapeutic education | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Follow-up | Intervention Type: OTHER; Name: Therapeutic education; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Follow-up; Assigned to Arm(s): 2
B: Arm Label: Lifestyle Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle Intervention | Arm Label: Health and Wellness; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle Intervention; Assigned to Arm(s): Lifestyle Intervention
C: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Other: Lifestyle intervention, Behavioral: Physical activity, dietetic counselling | Arm Label: Control; Type: NO_INTERVENTION; Interventions: Other: Control | Intervention Type: OTHER; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Physical activity, dietetic counselling; Assigned to Arm(s): Lifestyle intervention
D: Arm Label: Intensive Counseling Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary and lifestyle counseling | Arm Label: Routine care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary and lifestyle counseling; Assigned to Arm(s): Intensive Counseling Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Pregnant Women Education in Case of Overweight or Obesity on Risk of Child Overweight and Pregnancy Outcome
Brief Summary: Metabolic environment of the foetus during pregnancy in obese women is altered and the child exposed at an increased risk of obesity. Rapid infancy and childhood weight gain is associated with subsequent obesity.

The purpose of the study is to test the efficacy of an educational intervention during pregnancy in obese or overweight women, on the reduction of rapid infancy weight gain in the two first years of life.


Options:
A: Arm Label: myo-inositol; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: myo-inositol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: folic acid 400 mcg | Intervention Type: DIETARY_SUPPLEMENT; Name: myo-inositol; Assigned to Arm(s): myo-inositol | Intervention Type: OTHER; Name: folic acid 400 mcg; Assigned to Arm(s): placebo
B: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Behavioral: specific training program | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: standard | Intervention Type: OTHER; Name: standard; Assigned to Arm(s): control | Intervention Type: BEHAVIORAL; Name: specific training program; Assigned to Arm(s): exercise
C: Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Arm Label: Weight Management Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Management | Intervention Type: BEHAVIORAL; Name: Weight Management; Assigned to Arm(s): Weight Management Counseling | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Therapeutic education | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Follow-up | Intervention Type: OTHER; Name: Therapeutic education; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Follow-up; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase I Trial of Conditionally Replication-Competent Adenovirus (DNX-2401, Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
Brief Summary: The goal of this clinical research study is to find the highest tolerable dose of DNX-2401 that can be injected directly into brain tumors and into the surrounding brain tissue where tumor cells can multiply. A second goal is to study how the new drug DNX-2401 affects brain tumor cells and the body in general.


Options:
A: Arm Label: Group A: DNX-2401; Type: EXPERIMENTAL; Interventions: Drug: DNX-2401 | Arm Label: Group B: DNX-2401 + Surgery; Type: EXPERIMENTAL; Interventions: Drug: DNX-2401, Procedure: Tumor Removal | Intervention Type: DRUG; Name: DNX-2401; Assigned to Arm(s): Group A: DNX-2401, Group B: DNX-2401 + Surgery | Intervention Type: PROCEDURE; Name: Tumor Removal; Assigned to Arm(s): Group B: DNX-2401 + Surgery
B: Arm Label: Carbon Ion Radiotherapy; Type: EXPERIMENTAL; Interventions: Radiation: Carbon Ion Radiotherapy | Arm Label: Standard Treatment: Fractionated Stereotacitc Radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Fractionated Stereotactic Radiotherapy (FSRT) | Intervention Type: RADIATION; Name: Carbon Ion Radiotherapy; Assigned to Arm(s): Carbon Ion Radiotherapy | Intervention Type: RADIATION; Name: Fractionated Stereotactic Radiotherapy (FSRT); Assigned to Arm(s): Standard Treatment: Fractionated Stereotacitc Radiotherapy
C: Arm Label: ARM A - Regorafenib; Type: EXPERIMENTAL; Interventions: Drug: Regorafenib | Arm Label: ARM B - Lomustine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lomustine | Intervention Type: DRUG; Name: Regorafenib; Assigned to Arm(s): ARM A - Regorafenib | Intervention Type: DRUG; Name: Lomustine; Assigned to Arm(s): ARM B - Lomustine
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: VB-111 + bevacizumab | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bevacizumab | Intervention Type: DRUG; Name: VB-111 + bevacizumab; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Arm 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole as Adjunctive Therapy to Mechanical Treatment of Patients With Chronic Periodontitis
Brief Summary: The purpose of this study is to assess the clinical and microbiological effectiveness of the moxifloxacin compared with the combination ciprofloxacin - metronidazole, when used as adjunctive therapy to scaling and root planning for the treatment of advanced chronic periodontitis.


Options:
A: Arm Label: scaling and root planing; Type: PLACEBO_COMPARATOR; Interventions: Other: scaling and root planing | Arm Label: scaling and systemic moxifloxacin; Type: EXPERIMENTAL; Interventions: Other: scaling and systemic moxifloxacin | Intervention Type: OTHER; Name: scaling and systemic moxifloxacin; Assigned to Arm(s): scaling and systemic moxifloxacin | Intervention Type: OTHER; Name: scaling and root planing; Assigned to Arm(s): scaling and root planing
B: Arm Label: Moxifloxacin; Type: EXPERIMENTAL; Interventions: Drug: moxifloxacin | Arm Label: Ciprofloxacin plus metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ciprofloxacin plus metronidazole | Intervention Type: DRUG; Name: moxifloxacin; Assigned to Arm(s): Moxifloxacin | Intervention Type: DRUG; Name: Ciprofloxacin plus metronidazole; Assigned to Arm(s): Ciprofloxacin plus metronidazole
C: Arm Label: amoxicillin+metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin, Drug: Metronidazole | Arm Label: moxifloxacin; Type: EXPERIMENTAL; Interventions: Drug: Moxifloxacin | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): amoxicillin+metronidazole | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): amoxicillin+metronidazole | Intervention Type: DRUG; Name: Moxifloxacin; Assigned to Arm(s): moxifloxacin
D: Arm Label: YH14642 A-I; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-II; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-III; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: Active Comparator B; Type: ACTIVE_COMPARATOR; Interventions: Drug: INSADOL[Zea mays L. extract] 35mg Tab | Arm Label: Active Comparator C; Type: ACTIVE_COMPARATOR; Interventions: Drug: DENTISTA[Doxycycline hyclate] 20mg Cap | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-I | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-II | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-III | Intervention Type: DRUG; Name: INSADOL[Zea mays L. extract] 35mg Tab; Assigned to Arm(s): Active Comparator B | Intervention Type: DRUG; Name: DENTISTA[Doxycycline hyclate] 20mg Cap; Assigned to Arm(s): Active Comparator C | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)
Brief Summary: This study will test the effectiveness of two different treatments for children and adolescents who have gained weight on their antipsychotic medications.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aripiprazole or Perphenazine | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Metformin | Intervention Type: DRUG; Name: Aripiprazole or Perphenazine; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine; Assigned to Arm(s): 1
B: Arm Label: Bupropion SR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion SR | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Bupropion SR; Assigned to Arm(s): Bupropion SR | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo
C: Arm Label: Low Dose; Type: EXPERIMENTAL; Interventions: Drug: Samidorphan (Low Dose), Drug: Olanzapine | Arm Label: Medium Dose; Type: EXPERIMENTAL; Interventions: Drug: Samidorphan (Medium Dose), Drug: Olanzapine | Arm Label: High Dose; Type: EXPERIMENTAL; Interventions: Drug: Samidorphan (High Dose), Drug: Olanzapine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Olanzapine | Intervention Type: DRUG; Name: Samidorphan (Low Dose); Assigned to Arm(s): Low Dose | Intervention Type: DRUG; Name: Samidorphan (Medium Dose); Assigned to Arm(s): Medium Dose | Intervention Type: DRUG; Name: Samidorphan (High Dose); Assigned to Arm(s): High Dose | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): High Dose, Low Dose, Medium Dose, Placebo
D: Arm Label: Melatonin; Type: EXPERIMENTAL; Interventions: Drug: Melatonin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Melatonin; Assigned to Arm(s): Melatonin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Phosphate Binding With Sevelamer Carbonate Improve Cardiovascular Structure and Function in Patients With Early Chronic Kidney Disease?
Brief Summary: The purpose of this study is to determine whether lowering phosphate in patients with early chronic kidney disease with the phosphate binder sevelamer has beneficial effects on cardiovascular structure and function.


Options:
A: Arm Label: 900 mg Phosphate Diet-LC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lanthanum Carbonate, Other: 900 mg Phosphate Diet | Arm Label: Ad Libitum Diet-LC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lanthanum Carbonate, Other: Ad Libitum Diet | Arm Label: 900 mg Phosphate Diet-LC Placebo; Type: ACTIVE_COMPARATOR; Interventions: Other: 900 mg Phosphate Diet, Drug: LC Placebo | Arm Label: Ad Libitum Diet-LC Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: LC Placebo, Other: Ad Libitum Diet | Intervention Type: DRUG; Name: Lanthanum Carbonate; Assigned to Arm(s): 900 mg Phosphate Diet-LC, Ad Libitum Diet-LC | Intervention Type: OTHER; Name: 900 mg Phosphate Diet; Assigned to Arm(s): 900 mg Phosphate Diet-LC, 900 mg Phosphate Diet-LC Placebo | Intervention Type: DRUG; Name: LC Placebo; Assigned to Arm(s): 900 mg Phosphate Diet-LC Placebo, Ad Libitum Diet-LC Placebo | Intervention Type: OTHER; Name: Ad Libitum Diet; Assigned to Arm(s): Ad Libitum Diet-LC, Ad Libitum Diet-LC Placebo
B: Arm Label: Sevelamer HCl; Type: EXPERIMENTAL; Interventions: Drug: Sevelamer HCl | Arm Label: Calcium-based binder; Type: ACTIVE_COMPARATOR; Interventions: Drug: Calcium-based phosphate binder | Intervention Type: DRUG; Name: Sevelamer HCl; Assigned to Arm(s): Sevelamer HCl | Intervention Type: DRUG; Name: Calcium-based phosphate binder; Assigned to Arm(s): Calcium-based binder
C: Arm Label: Placebo 20mg; Type: PLACEBO_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 60 mg extender; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 60 mg; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 20mg extender; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 20mg; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: Placebo 60mg; Type: PLACEBO_COMPARATOR; Interventions: Other: chewing gum | Intervention Type: OTHER; Name: chewing gum; Assigned to Arm(s): K2CG 20mg, K2CG 20mg extender, K2CG 60 mg, K2CG 60 mg extender, Placebo 20mg, Placebo 60mg
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sevelamer carbonate | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sevelamer carbonate; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trans-Nasal Cooling With the RhinoChill Device Following Cardiac Arrest: A Pilot Study
Brief Summary: The purpose of the study was to demonstrate the safety and feasibility of early intranasal cooling prior to return of spontaneous circulation (ROSC) in the emergency medical services (EMS) environment. It was hypothesized that cooling during the resuscitation attempt would increase ROSC and subsequent survival. The study was not powered to demonstrate statistically-significant differences in any outcome parameter, but was intended as an exploratory study only.


Options:
A: Arm Label: RhinoChill; Type: EXPERIMENTAL; Interventions: Device: RhinoChill | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: DEVICE; Name: RhinoChill; Assigned to Arm(s): RhinoChill | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: Target Temperature 33°C; Type: EXPERIMENTAL; Interventions: Procedure: Target Temperature 33°C | Arm Label: Target Temperature 36°C; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Target temperature 36°C | Intervention Type: PROCEDURE; Name: Target temperature 36°C; Assigned to Arm(s): Target Temperature 36°C | Intervention Type: PROCEDURE; Name: Target Temperature 33°C; Assigned to Arm(s): Target Temperature 33°C
C: Arm Label: control treatment; Type: NO_INTERVENTION; Interventions: Other: Rapid infusion of 2 liters of 4oC normal saline, Drug: Rapid infusion of cold normal saline | Intervention Type: OTHER; Name: Rapid infusion of 2 liters of 4oC normal saline; Assigned to Arm(s): control treatment | Intervention Type: DRUG; Name: Rapid infusion of cold normal saline; Assigned to Arm(s): control treatment
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Prehospital intra-nasal cooling with RhinoChill | Intervention Type: DEVICE; Name: Prehospital intra-nasal cooling with RhinoChill; Assigned to Arm(s): Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity
Brief Summary: Preventing the onset of pediatric obesity and diabetes in Latino families

The investigators will conduct a randomized controlled trial of a family-based community centered intervention. One-hundred Latino families with children ages 3-5 will be randomly allocated to either the intervention group (a 3-month skills building program to improve nutrition and aerobic activity for child-parent dyads) or a control group (literacy promotion). Through an active partnership with Nashville Metro Parks and Recreation and the Division of General Pediatrics at the Vanderbilt Children's Hospital, the investigators will: 1) Implement an intervention for Latino families with young children that includes parent training, behavior modification training, nutrition education, and physical activity promotion; 2) Evaluate how this intervention affects growth trajectories in children; 3) Evaluate how this intervention affects parenting practices for Latino families to improve nutrition and physical activity; and 4) Evaluate the ability to link families into a pediatric medical home if they have none identified. By developing innovative family-focused interventions, finding solutions to health conditions such as obesity and diabetes could be realized-con la familia.


Options:
A: Arm Label: AA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Arm Label: HA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Intervention Type: BEHAVIORAL; Name: Increase vegetable intake in pre-school children; Assigned to Arm(s): AA - Increase vegetable intake, HA - Increase vegetable intake
B: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
C: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Lifestyle counseling; Assigned to Arm(s): Lifestyle counseling
D: Intervention Type: BEHAVIORAL; Name: Targeted parental instruction for positive lifestyle change with follow-up calls.; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity
Brief Summary: Preventing the onset of pediatric obesity and diabetes in Latino families

The investigators will conduct a randomized controlled trial of a family-based community centered intervention. One-hundred Latino families with children ages 3-5 will be randomly allocated to either the intervention group (a 3-month skills building program to improve nutrition and aerobic activity for child-parent dyads) or a control group (literacy promotion). Through an active partnership with Nashville Metro Parks and Recreation and the Division of General Pediatrics at the Vanderbilt Children's Hospital, the investigators will: 1) Implement an intervention for Latino families with young children that includes parent training, behavior modification training, nutrition education, and physical activity promotion; 2) Evaluate how this intervention affects growth trajectories in children; 3) Evaluate how this intervention affects parenting practices for Latino families to improve nutrition and physical activity; and 4) Evaluate the ability to link families into a pediatric medical home if they have none identified. By developing innovative family-focused interventions, finding solutions to health conditions such as obesity and diabetes could be realized-con la familia.


Options:
A: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Lifestyle counseling; Assigned to Arm(s): Lifestyle counseling
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: 6 months of healthy physical activity | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: 6 months of healthy physical activity; Assigned to Arm(s): 1
C: Arm Label: School Only; Type: EXPERIMENTAL; Interventions: Behavioral: School | Arm Label: School + Family; Type: EXPERIMENTAL; Interventions: Behavioral: School, Behavioral: Family | Arm Label: School + About Eating; Type: EXPERIMENTAL; Interventions: Behavioral: School, Behavioral: About Eating | Arm Label: School + Family + About Eating; Type: EXPERIMENTAL; Interventions: Behavioral: School, Behavioral: Family, Behavioral: About Eating | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: School; Assigned to Arm(s): School + About Eating, School + Family, School + Family + About Eating, School Only | Intervention Type: BEHAVIORAL; Name: Family; Assigned to Arm(s): School + Family, School + Family + About Eating | Intervention Type: BEHAVIORAL; Name: About Eating; Assigned to Arm(s): School + About Eating, School + Family + About Eating
D: Arm Label: Team Nutriathlon intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Team Nutriathlon intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Team Nutriathlon intervention; Assigned to Arm(s): Team Nutriathlon intervention

Answer: A